Elisabeth M. Paietta

Holistic Medicine
20 Old Mamaroneck Rd
Apt. # 6e
White Plains, NY 10605

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 161 publications

Author Correction: Signalling thresholds and negative B-cell selection in acute lymphoblastic leukaemia.

Author Correction: Signalling thresholds and negative B-cell selection in acute lymphoblastic leukaemia.

Journal: Nature
Published: September 03, 2026

Bone marrow biopsy characteristics at nadir after intensive induction therapy do not predict outcomes in adult acute myeloid leukemia patients: an analysis of ECOG-ACRIN clinical trials.

Bone marrow biopsy characteristics at nadir after intensive induction therapy do not predict outcomes in adult acute myeloid leukemia patients: an analysis of ECOG-ACRIN clinical trials.

Journal: Haematologica
Published: May 04, 2026

Dynamic feedback control of oncogenic tyrosine kinase signaling in acute leukemia.

Dynamic feedback control of oncogenic tyrosine kinase signaling in acute leukemia.

Journal: Science signaling
Published: February 10, 2026

Long-term follow-up of a pediatric regimen for AYA with Ph-negative ALL: 10-year survival of CALGB 10403 (alliance).

Long-term follow-up of a pediatric regimen for AYA with Ph-negative ALL: 10-year survival of CALGB 10403 (alliance).

Journal: Blood advances
Published: January 08, 2026

Long-term Follow-up of a Pediatric Regimen for AYA with Ph-negative ALL: 10-year Survival of CALGB 10403 (Alliance).

Long-term Follow-up of a Pediatric Regimen for AYA with Ph-negative ALL: 10-year Survival of CALGB 10403 (Alliance).

Journal: Blood advances
Published: January 08, 2026

Early assessment of treatment response in AML using FLT PET/cT: a trial of the ECOG-ACRIN Cancer Research Group (EAI141).

Early assessment of treatment response in AML using FLT PET/cT: a trial of the ECOG-ACRIN Cancer Research Group (EAI141).

Journal: Leukemia & lymphoma
Published: November 12, 2025

Elevated levels of TNF and its targets characterize better-risk older acute myeloid leukemia patients.

Elevated levels of TNF and its targets characterize better-risk older acute myeloid leukemia patients.

Journal: Leukemia
Published: October 21, 2025

Survival after intensive therapy or clofarabine in fit older adults with acute myeloid leukemia: E2906 phase 3 trial.

Survival after intensive therapy or clofarabine in fit older adults with acute myeloid leukemia: E2906 phase 3 trial.

Journal: Blood neoplasia
Published: October 06, 2025

CRLF2 rearrangement and extramedullary disease in B-cell acute lymphoblastic leukemia: a possible link?

CRLF2 rearrangement and extramedullary disease in B-cell acute lymphoblastic leukemia: a possible link?

Journal: Blood advances
Published: September 18, 2025

CRLF2-rearrangement and Extramedullary Disease in B-cell Acute Lymphoblastic Leukemia: A Possible Link?

CRLF2-rearrangement and Extramedullary Disease in B-cell Acute Lymphoblastic Leukemia: A Possible Link?

Journal: Blood advances
Published: September 18, 2025

Long-Read Whole-Transcriptome Sequencing and Selective Gene Panel Profiling Enable Sensitive Detection of Fusion Oncogenes in Pediatric B-Cell Acute Lymphoblastic Leukemia.

Long-Read Whole-Transcriptome Sequencing and Selective Gene Panel Profiling Enable Sensitive Detection of Fusion Oncogenes in Pediatric B-Cell Acute Lymphoblastic Leukemia.

Journal: The Journal of molecular diagnostics : JMD
Published: August 28, 2025

Differentiation-dependent EBF1 activity determines CD22 transcription and leukemia sensitivity to inotuzumab ozogamicin.

Differentiation-dependent EBF1 activity determines CD22 transcription and leukemia sensitivity to inotuzumab ozogamicin.

Journal: Blood
Published: December 30, 2024
Showing 1-12 of 161

Last Updated: 09/26/2026